Ligand ID: 8QP


Drugbank ID:
DB00749
(Etodolac)



Indication:
For acute and long-term management of signs and symptoms of osteoarthritis and rheumatoid arthritis, as well as for the management of pain.


Get human targets for 8QP in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND '8QP' AND SARS-RELATED PROTEINS ONLY

1) User may click on the DrReposER ID (the first column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera throuh AutoDock Vina.


DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
View Interface RMSD Seq.
Identity (%)
HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
1uk3 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
GLU B 240
LEU B 205
LEU B 242
LEU B 227
ALA B 234
1.60A17.24
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
1zv8 E2 GLYCOPROTEIN
(SARSr-CoV)
5 / 12
LYS J   4
LEU K  48
LEU I  44
LEU G  44
ILE L   5
1.54A4.71
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
2acf REPLICASE
POLYPROTEIN 1AB
(SARS-COV
Tor2)
5 / 12
LYS B 245
LEU C 319
LEU C 322
LEU C 308
GLU C 344
1.24A13.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
2ajf ACE2
(Homo
sapiens)
5 / 12
LEU A 558
LEU A 320
ILE A 544
ALA A 550
GLU A 549
1.58A22.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
2d2d 3C-LIKE PROTEINASE
(SARSr-CoV)
4 / 8
ALA B  70
VAL B  18
THR B  35
GLY B  15
1.31A17.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
2fe8 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)
5 / 12
GLU C 239
LEU C 217
LEU C 235
LEU C 186
ALA C 205
1.54A19.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
2gtb 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
LEU A 205
LEU A 268
LEU A 271
ILE A 281
GLU A 288
1.65A17.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
2k7x REPLICASE
POLYPROTEIN 1AB MAIN
PROTEASE
(SARS-COV
Sino1-11)
5 / 12
LEU A 205
LEU A 242
HIS A 246
LEU A 227
ALA A 234
1.66A12.44
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
2xyq PUTATIVE 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)
5 / 12
LEU A 126
LEU A  59
LEU A  54
ILE A 207
ALA A 209
1.64A18.20
None
NA  A1295 (-4.3A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
2xyr PUTATIVE 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)
5 / 12
LEU A 126
LEU A  59
LEU A  54
ILE A 207
ALA A 209
1.63A18.78
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
3atw 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
LEU A 205
LEU A 268
LEU A 271
ILE A 281
GLU A 288
1.60A16.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
3bgf SPIKE PROTEIN S1
(SARSr-CoV)
5 / 12
TYR S 367
LEU S 355
LEU S 421
LEU S 499
ALA S 371
1.62A14.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
3bgf F26G19 FAB
(Mus
musculus)
4 / 8
PHE L 118
SER L 116
THR L 114
GLY H 141
1.28A15.83
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
3bgf F26G19 FAB
(Mus
musculus)
5 / 12
LEU L  54
LEU L  47
LEU L  73
ILE L  75
GLU L  79
1.56A15.83
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
3d0g ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)
4 / 8
ARG A 169
ALA A 264
VAL A 487
GLY A 272
1.18A22.03
CL  A 902 (-4.1A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
3d62 3C-LIKE PROTEINASE
(SARSr-CoV)
4 / 8
ALA A  70
VAL A  18
THR A  35
GLY A  15
1.31A17.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
3e9s NSP3
(SARSr-CoV)
5 / 12
GLU A 239
LEU A 217
LEU A 235
LEU A 186
ALA A 205
1.63A19.22
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
3ebn REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)
5 / 12
GLU C 270
LEU C 208
LEU A 271
LEU A 272
ALA A 266
1.51A12.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
3m3v 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
LEU A 205
LEU A 268
LEU A 271
ILE A 281
GLU A 288
1.56A17.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
3r24 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)
5 / 12
LEU A 126
LEU A  59
LEU A  54
ILE A 207
ALA A 209
1.63A21.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
3scl ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)
4 / 8
ARG B 169
ALA B 264
VAL B 487
GLY B 272
1.25A22.00
CL  B 902 (-4.5A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
4m0w REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)
5 / 12
GLU A 239
LEU A 217
LEU A 235
LEU A 186
ALA A 205
1.49A21.59
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
4m0w REPLICASE
POLYPROTEIN 1A
UBIQUITIN
(Bos
taurus;
SARSr-CoV)
4 / 8
ARG A 184
ALA B  46
THR A 232
GLY A 210
1.29A21.59
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
4mm3 PAPAIN-LIKE
PROTEINASE
(SARSr-CoV)
5 / 12
GLU B 239
LEU B 217
LEU B 235
LEU B 186
ALA B 205
1.49A19.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
4ow0 PAPAIN-LIKE PROTEASE
(SARS-COV
Urbani)
4 / 8
ARG A 184
SER A 222
THR A 232
GLY A 210
1.11A19.29
None
None
None
S88  B 902 (-3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
5e6j REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)
4 / 8
ARG D 184
VAL D 221
THR D 219
GLY D 210
1.29A21.40
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)
4 / 8
LYS A 311
ALA A 308
VAL A 312
PHE A 444
1.26A19.72
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
5tl6 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)
4 / 8
ARG B 184
VAL B 221
THR B 219
GLY B 210
1.29A19.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
5tl7 REPLICASE
POLYPROTEIN 1AB
UBIQUITIN-LIKE
PROTEIN ISG15
(Mus
musculus;
SARSr-CoV)
5 / 12
GLU B 204
LEU B 217
LEU B 186
ILE B 223
GLU A  87
1.47A19.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
5wrg SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 12
GLU A 730
LEU A 978
LEU A 959
ALA A 971
GLU A 972
1.50A19.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
5wrg SPIKE GLYCOPROTEIN
(SARSr-CoV)
4 / 8
ALA C 765
VAL C 767
THR C 856
GLY B 682
1.23A19.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
5x4r S PROTEIN
(MERS-CoV)
5 / 12
TYR A 287
LEU A 265
LEU A 284
LEU A 169
ILE A 290
1.63A19.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
5x58 SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)
4 / 8
ALA B 595
VAL B 594
SER B 673
GLY B 638
1.01A19.35
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
5x59 S PROTEIN
(MERS-CoV)
5 / 12
TYR A 287
LEU A 265
LEU A 284
LEU A 169
ILE A 290
1.62A18.59
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)
5 / 12
GLU A 730
LEU A 978
LEU A 959
ALA A 971
GLU A 972
1.38A19.35
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
5y3e REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)
5 / 12
GLU A 239
LEU A 217
LEU A 235
LEU A 186
ALA A 205
1.42A19.06
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
5zvm PAN-COV INHIBITORY
PEPTIDE EK1
SPIKE GLYCOPROTEIN
(SARSr-CoV;
synthetic
construct)
5 / 12
LEU A 927
LEU A 930
LEU c  18
ALA C 926
GLU b  21
1.53A8.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
5zvm PAN-COV INHIBITORY
PEPTIDE EK1
SPIKE GLYCOPROTEIN
(SARSr-CoV;
synthetic
construct)
5 / 12
LYS a  24
LEU b  25
LEU C 927
ALA B 926
GLU a  21
1.47A6.49
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6acg SPIKE GLYCOPROTEIN
(SARSr-CoV)
4 / 8
ALA B 765
VAL B 767
THR B 856
GLY C 682
0.92A19.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
6acj SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 12
TYR A 622
LEU A 597
ILE A 584
ALA A 595
GLU A 593
1.45A19.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6acj ACE2
(Homo
sapiens)
4 / 8
ARG D 169
ALA D 264
VAL D 487
GLY D 272
1.13A22.40
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
6ack ACE2
(Homo
sapiens)
5 / 12
LEU D  29
LEU D 100
LEU D 391
ALA D  36
GLU D  35
1.48A22.40
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6crv SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)
5 / 8
ARG B 747
PHE A 952
SER A 985
THR A 988
GLY B 739
1.66A19.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6crw SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)
4 / 8
ARG C1089
SER C1052
THR C 698
GLY A 873
1.06A19.38
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
6cs1 SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)
5 / 12
TYR A 622
LEU A 597
ILE A 584
ALA A 595
GLU A 593
1.51A19.38
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6cs2 ACE2
(Homo
sapiens)
4 / 8
ARG D 169
ALA D 264
VAL D 487
GLY D 272
1.31A22.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6lzg ACE2
(Homo
sapiens)
4 / 8
ARG A 169
ALA A 264
VAL A 487
GLY A 272
1.13A22.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6m18 ACE2
(Homo
sapiens)
4 / 8
ARG D 169
ALA D 264
VAL D 487
GLY D 272
1.05A22.13
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6nb6 SPIKE GLYCOPROTEIN
(SARSr-CoV)
4 / 8
ALA C 765
VAL C 767
THR C 856
GLY A 682
1.22A18.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
6nb6 SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 12
TYR A 622
LEU A 597
ILE A 584
ALA A 595
GLU A 593
1.44A18.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
6nur NSP12
(SARSr-CoV)
5 / 12
GLU A 136
LEU A 131
LEU A 142
LEU A 146
ILE A 171
1.50A20.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)
4 / 8
ALA H 125
VAL H 211
THR H 193
GLY H 139
1.72A15.09
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)
4 / 8
VAL H  11
PHE H 146
SER H 112
THR H  87
1.70A15.09
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6w41 CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)
4 / 8
ARG L 142
ALA L 144
VAL L 146
SER L 177
1.54A14.60
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6w41 CR3022 FAB HEAVY
CHAIN
CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)
4 / 8
ALA H 168
VAL H 169
SER L 176
THR L 164
1.54A15.09
None
GOL  L 301 (-4.5A)
GOL  L 301 (-3.1A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)
5 / 12
TYR B  27
LYS B   0
LEU L  79
ILE L  54
GLU L  61
1.76A16.27
None
MLI  B 303 (-4.6A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6yla HEAVY CHAIN
(Homo
sapiens)
4 / 8
ALA B 129
VAL B 215
THR B 197
GLY B 143
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)
5 / 12
TYR B  27
GLU L  87
LEU L  79
LEU L  53
ALA L  90
1.63A16.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6yla HEAVY CHAIN
(Homo
sapiens)
4 / 8
ALA H  97
VAL H 108
SER H 100
THR H 104
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6yla HEAVY CHAIN
(Homo
sapiens)
4 / 8
ALA B  97
VAL B 108
SER B 100
THR B 104
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)
5 / 12
TYR H  27
LYS H   0
LEU C  79
ILE C  54
GLU C  61
1.75A16.27
None
MLI  B 303 (-4.3A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6yla LIGHT CHAIN
(Homo
sapiens)
4 / 8
ARG L 148
ALA L 150
VAL L 152
SER L 183
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)
5 / 12
TYR H  27
GLU C  87
LEU C  79
LEU C  53
ALA C  90
1.63A16.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6ym0 HEAVY CHAIN
(Homo
sapiens)
4 / 8
ALA H  97
VAL H 108
SER H 100
THR H 104
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6ym0 HEAVY CHAIN
(Homo
sapiens)
4 / 8
ALA H 129
VAL H 215
THR H 197
GLY H 143
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6yor IGG L CHAIN
(Homo
sapiens)
4 / 8
ARG C 148
ALA C 150
VAL C 152
SER C 183
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6yor IGG H CHAIN
(Homo
sapiens)
4 / 8
ALA B  97
VAL B 108
SER B 100
THR B 104
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6yor IGG H CHAIN
(Homo
sapiens)
4 / 8
ALA H  97
VAL H 108
SER H 100
THR H 104
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA613_1
(SERUM ALBUMIN)
6yor IGG L CHAIN
(Homo
sapiens)
4 / 8
ARG L 148
ALA L 150
VAL L 152
SER L 183
1.56A
None